Amended Statement of Ownership (sc 13g/a)
February 12 2019 - 4:49PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of
1934
(Amendment No. 2)
*
AC Immune SA
|
(Name of Issuer)
|
|
Common Shares
|
(Title of Class of Securities)
|
|
H00263 105
|
(CUSIP Number)
|
|
December 31, 2018
|
(Date of Event which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to
which this Schedule is filed:
* The remainder of this cover page shall
be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for
any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder
of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of
1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions
of the Act (however,
see
the
Notes
).
Persons
who respond to the collection of information contained in this form are not required to respond unless the form displays a currently
valid OMB control number.
1.
|
NAMES OF REPORTING PERSONS
Varuma AG
|
|
|
2.
|
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
|
(a)
o
|
|
|
(b)
o
|
|
|
|
3.
|
SEC USE ONLY
|
4.
|
CITIZENSHIP OR PLACE OF ORGANIZATION
Basel, Switzerland
|
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
|
5.
|
SOLE VOTING POWER 11,999,999
|
6.
|
SHARED VOTING POWER 0
|
7.
|
SOLE DISPOSITIVE POWER 11,999,999
|
8.
|
SHARED DISPOSITIVE POWER 0
|
9.
|
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
11,999,999
|
10.
|
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES
CERTAIN SHARES
|
|
o
|
11.
|
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
17.81% (1)
|
12.
|
TYPE OF REPORTING PERSON
CO
|
|
(1)
|
Based on 67,362,690 common shares outstanding as reported by the Issuer in its Form F-3 registration statement filed with the
Securities and Exchange Commission on August 24, 2018.
|
|
Item 1(a).
|
Name of Issuer:
|
AC Immune SA
|
Item 1(b).
|
Address of Issuer’s Principal Executive Offices:
|
EPFL Innovation Park, bâtiment B,
1015 Lausanne, Switzerland
|
Item 2(a).
|
Name of Person Filing:
|
Varuma AG
|
Item 2(b).
|
Address of Principal Business Office or, if None, Residence:
|
Aeschenvorstadt 55, 4051 Basel, Switzerland
Switzerland
|
Item 2(d).
|
Title of Class of Securities:
|
Common shares, nominal value CHF 0.02 per
share
H00263 105
|
Item 3.
|
If this Statement is Filed Pursuant to Rule 13d-1(b), or 13d-2(b) or (c), Check Whether the Person Filing is a:
|
N/A
Provide the following information regarding
the aggregate number and percentage of the class of securities of issuer identified in Item 1.
|
(a)
|
Amount beneficially owned: 11,999,999
|
|
(b)
|
Percent of class: 17.81%, based on 67,362,690 common shares outstanding as of August 24, 2018.
|
|
(c)
|
Number of shares as to which such person has:
|
|
(i)
|
Sole power to vote or to direct the vote: 11,999,999
|
|
(ii)
|
Shared power to vote or to direct the vote: 0
|
|
(iii)
|
Sole power to dispose or to direct the disposition of: 11,999,999
|
|
(iv)
|
Shared power to dispose or to direct the disposition of: 0
|
|
Item 5.
|
Ownership of Five Percent or Less of a Class.
|
N/A
|
Item 6.
|
Ownership of More than Five Percent on Behalf of Another Person.
|
N/A
|
Item 7.
|
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company.
|
N/A
|
Item 8.
|
Identification and Classification of Members of the Group.
|
N/A
|
Item 9.
|
Notice of Dissolution of Group.
|
N/A
N/A
SIGNATURE
After reasonable inquiry and to the best
of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
February 12, 2019
|
(Date)
|
|
/s/ Rudolf Maag
|
(Signature)
|
|
Rudolf Maag
Member of the Board of Varuma AG
|
(Name/Title)
|
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Aug 2024 to Sep 2024
AC Immune (NASDAQ:ACIU)
Historical Stock Chart
From Sep 2023 to Sep 2024